A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 31/00 (2006.01) A61K 31/555 (2006.01)
Patent
CA 2323158
A method for treating CMV infection and disease conditions associated therewith is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N,N'-1,1'-((2"-ethoxy)-3'''(O)-4'''-(N,N-dimethylamino)- butane)-bis-(3,3'-indoly1)]-1(H)-pyrrole-2,5-dione hydrochloride salt.
Cette invention se rapporte à un procédé pour traiter les infections à cytomégalovirus (CMV) et les états pathologiques associés à ces infections, notamment en utilisant l'inhibiteur de protéine-kinase C (PKC) à sélectivité pour les isozymes, à savoir le sel hydrochlorure de (S)-3,4-[N,N'-1,1'-((2''-éthoxy)-3'''(O)-4'''-(N,N-diméthylamino)-butane)-bis-(3-3'-indolyl)]-1(H)-pyrrole-2,5-dione.
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Use of pkc inhibitors for the manufacture of a medicament... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of pkc inhibitors for the manufacture of a medicament..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pkc inhibitors for the manufacture of a medicament... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1615985